BioAge Labs Inc (BIOA): Next-Year EPS Estimate 26.56%
As of 2026-07-17, BioAge Labs Inc (BIOA) has a next-year EPS growth estimate of 26.56%. Featured in 2 EPS revision reports, most recently on 2026-06-16.
On 2026-07-14, analyst consensus for BIOA's next-year EPS growth shifted from 26.58% to 26.56% — a negative change of 0.02 percentage points. The revised estimate has been sustained across 4 subsequent trading sessions. Current-year growth is projected at -14.15%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 26.56%
- EPS growth this year
- -14.15%
- EPS next quarter (est)
- -$0.61
- Last price
- $22.81
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-07-17 | 26.56% | -14.15% | -$0.61 | $22.81 |
| 2026-07-16 | 26.56% | -14.15% | -$0.61 | $22.16 |
| 2026-07-15 | 26.56% | -14.15% | -$0.61 | $22.70 |
| 2026-07-14 | 26.56% | -14.15% | -$0.61 | $22.78 |
| 2026-07-13 | 26.58% | -14.17% | -$0.61 | $21.78 |
| 2026-07-12 | 26.58% | -14.17% | -$0.61 | $24.34 |
| 2026-07-09 | 26.58% | -14.17% | -$0.61 | $24.89 |
| 2026-07-08 | 26.58% | -14.17% | -$0.61 | $23.63 |
| 2026-07-07 | 26.58% | -14.17% | -$0.61 | $24.40 |
| 2026-07-06 | 26.58% | -14.17% | -$0.61 | $24.84 |
| 2026-07-05 | 26.56% | -14.16% | -$0.61 | $25.10 |
| 2026-07-02 | 26.56% | -14.16% | -$0.61 | $25.10 |
| 2026-07-01 | 26.53% | -14.14% | -$0.61 | $24.26 |
| 2026-06-30 | 26.53% | -14.14% | -$0.61 | $24.51 |
| 2026-06-29 | 26.53% | -14.14% | -$0.61 | $24.95 |
| 2026-06-28 | 26.53% | -14.14% | -$0.61 | $23.76 |
| 2026-06-25 | 26.53% | -14.14% | -$0.61 | $22.62 |
| 2026-06-24 | 26.53% | -14.14% | -$0.61 | $22.83 |
| 2026-06-23 | 26.53% | -14.14% | -$0.61 | $22.32 |
| 2026-06-22 | 26.53% | -14.14% | -$0.61 | $21.47 |
| 2026-06-21 | 26.53% | -14.14% | -$0.61 | $20.77 |
| 2026-06-18 | 26.53% | -14.14% | -$0.61 | $20.77 |
| 2026-06-17 | 26.53% | -14.14% | -$0.61 | $19.99 |
| 2026-06-16 | 26.53% | -14.14% | -$0.61 | $20.49 |
| 2026-06-15 | 26.53% | -14.14% | -$0.61 | $19.84 |
| 2026-06-14 | 26.53% | -14.14% | -$0.61 | $18.04 |
| 2026-06-11 | 26.53% | -14.14% | -$0.61 | $16.45 |
| 2026-06-10 | 26.53% | -14.14% | -$0.61 | $15.48 |
| 2026-06-09 | 26.53% | -14.14% | -$0.61 | $15.80 |
| 2026-06-08 | 26.53% | -14.14% | -$0.61 | $15.51 |
Reports Featuring BIOA
Screen Performance
Aggregate stats across all 1864 tickers our top-EPS-revision screen has flagged over the past 107 days.
- Median return since detection
- +2.5%
- % of tickers in the green
- 55%
- Median return on winners
- +20.8%
- Large revisions captured
- 1048
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is BioAge Labs Inc's next-year EPS growth estimate?▾
As of 2026-07-17, BioAge Labs Inc (BIOA) has a next-year EPS growth estimate of 26.56%, based on analyst consensus.
When was the latest EPS estimate revision for BIOA?▾
The most recent revision occurred on 2026-07-14, when analysts adjusted the next-year EPS growth estimate from 26.58% to 26.56%.
What sector and industry does BioAge Labs Inc belong to?▾
BioAge Labs Inc operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. BIOA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. BioAge Labs Inc (BIOA) appears here because it was detected by our daily top-EPS-revision-performer screen.